Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132528) titled 'Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer' on Aug. 10.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Liaoning Cancer Hospital & Institute
Condition:
Gastric / Gastroesophageal Junction Adenocarcinoma
Intervention:
Drug: SOX plus PD-1 inhibitor
Recruitment Status: Not recruiting
Phase: Phas...